BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38340584)

  • 1. Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review.
    Gholamzad A; Khakpour N; Gholamzad M; Roudaki Sarvandani MR; Khosroshahi EM; Asadi S; Rashidi M; Hashemi M
    Pathol Res Pract; 2024 Mar; 255():155172. PubMed ID: 38340584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
    Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
    Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
    Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.
    Letafati A; Soheili R; Norouzi M; Soleimani P; Mozhgani SH
    Med Oncol; 2023 Sep; 40(10):295. PubMed ID: 37689806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.
    Iqbal M; Reljic T; Klocksieben F; Sher T; Ayala E; Murthy H; Bazarbachi A; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1695-1700. PubMed ID: 31132453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia/lymphoma.
    Jo T; Noguchi K; Sakai T; Kubota-Koketsu R; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
    Cancer Med; 2022 Sep; 11(17):3238-3250. PubMed ID: 35315593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
    Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region.
    Ashrafi F; Rahimzada M; Parandi M; Mirhosseini A; Mashkani B; Ahmadi Ghezeldasht S; Soltani A; Rafatpanah H; Mosavat A; Abdolrahim Rezaee S
    Gene; 2022 Dec; 847():146885. PubMed ID: 36108787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation.
    Miyamura F; Kako S; Yamagami H; Sato K; Sato M; Terasako K; Kimura SI; Nakasone H; Aoki S; Okuda S; Yamazaki R; Oshima K; Yoshinaga K; Higuchi T; Nishida J; Demitsu T; Kakehashi A; Kanda Y
    Int J Hematol; 2009 Oct; 90(3):397-401. PubMed ID: 19705056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and prognosis in 12 patients with adult T cell leukemia/lymphoma confirmed by HTLV-1 provirus gene detection].
    Wu ZJ; Zheng XY; Yang XZ; Liu TB; Yang T; Zheng ZH; Gao F; Chen CX; Li JG; Zhang CQ; Lin WQ; Zheng HY; Lin SX; Hu JD
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1027-1032. PubMed ID: 28088963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.
    Vicario M; Mattiolo A; Montini B; Piano MA; Cavallari I; Amadori A; Chieco-Bianchi L; Calabrò ML
    Front Microbiol; 2018; 9():1215. PubMed ID: 29951044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment approach for relapse of adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation].
    Kato K
    Rinsho Ketsueki; 2021; 62(5):505-511. PubMed ID: 34248128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
    Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
    J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma.
    Phillips AA
    Curr Opin Virol; 2023 Feb; 58():101289. PubMed ID: 36584476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.
    Malpica L; Pimentel A; Reis IM; Gotuzzo E; Lekakis L; Komanduri K; Harrington T; Barber GN; Ramos JC
    Blood Adv; 2018 Mar; 2(6):607-620. PubMed ID: 29545256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission.
    Hirosawa M; Yamaguchi T; Tanaka A; Kominato Y; Higashi T; Morimoto H; Tsukada J
    Ann Hematol; 2020 Mar; 99(3):599-607. PubMed ID: 32006150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma.
    Yoshimitsu M; White Y; Arima N
    Recent Results Cancer Res; 2014; 193():211-25. PubMed ID: 24008301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
    Kozako T; Yoshimitsu M; Fujiwara H; Masamoto I; Horai S; White Y; Akimoto M; Suzuki S; Matsushita K; Uozumi K; Tei C; Arima N
    Leukemia; 2009 Feb; 23(2):375-82. PubMed ID: 18830259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.
    Jo T; Kubota-Koketsu R; Kaneko Y; Sakai T; Noguchi K; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
    Cancer Immunol Immunother; 2023 Apr; 72(4):929-944. PubMed ID: 36181532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.